Safety and Pharmacokinetics (PK) of a Polyurethane Tenofovir Disoproxil Fumarate (TDF) Vaginal Ring
Status:
Completed
Trial end date:
2014-11-06
Target enrollment:
Participant gender:
Summary
This prospective, randomized, single-blinded, placebo controlled trial will examine the
safety and pharmacokinetics (PK) of a polyurethane tenofovir disoproxil fumarate (TDF)
vaginal ring when used continuously for 14 consecutive days.
The primary objective is to assess the safety of TDF vaginal rings when used continuously for
14 days by healthy, HIV-uninfected, sexually abstinent women, as compared with a placebo
vaginal ring.
Phase:
Phase 1
Details
Lead Sponsor:
Albert Einstein College of Medicine Albert Einstein College of Medicine of Yeshiva University
Collaborator:
National Institute of Allergy and Infectious Diseases (NIAID)